Mala Murthy - Jun 24, 2022 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Stock symbol
TDOC
Transactions as of
Jun 24, 2022
Transactions value $
-$151,242
Form type
4
Date filed
6/28/2022, 04:10 PM
Previous filing
Jun 3, 2022
Next filing
Mar 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +7.97K +34.08% 31.3K Jun 24, 2022 Direct F1
transaction TDOC Common Stock Sale -$151K -4.05K -12.93% $37.32 27.3K Jun 27, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Restricted Stock Units Options Exercise $0 -7.97K -100% $0.00* 0 Jun 24, 2022 Common Stock 7.97K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 Shares sold to cover the issuer's withholding obligation in respect of reporting person's award.
F3 On June 24, 2019, the reporting person was granted 31,872 restricted stock units, vesting as to 25% of the shares on February 20, 2020 with the remainder of the shares vesting in three equal annual installments beginning on the first anniversary of the grant date.